These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 17250791

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Novel approaches using natural killer cells in cancer therapy.
    Suck G.
    Semin Cancer Biol; 2006 Oct; 16(5):412-8. PubMed ID: 16914327
    [Abstract] [Full Text] [Related]

  • 4. Exploitation of alloreactive NK cells in adoptive immunotherapy of cancer.
    Ruggeri L, Mancusi A, Capanni M, Martelli MF, Velardi A.
    Curr Opin Immunol; 2005 Apr; 17(2):211-7. PubMed ID: 15766683
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [NK cell-based immunotherapy: new prospects and involvement of dendritic cells].
    Borg C, Taieb J, Terme M, Maruyama K, Flament C, Angevin E, Zitvogel L.
    Bull Cancer; 2003 Apr; 90(8-9):699-705. PubMed ID: 14609759
    [Abstract] [Full Text] [Related]

  • 8. Characterization of stem cell factor gene-modified human natural killer cell line, NK-92 cells: implication in NK cell-based adoptive cellular immunotherapy.
    Zhang J, Sun R, Wei H, Zhang J, Tian Z.
    Oncol Rep; 2004 May; 11(5):1097-106. PubMed ID: 15069553
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The biology of human natural killer cells.
    Whiteside TL, Herberman RB.
    Ann Ist Super Sanita; 1990 May; 26(3-4):335-48. PubMed ID: 2091502
    [Abstract] [Full Text] [Related]

  • 11. [Combined cell therapy by using dendritic cells, T-cells and NK cells to human polymorphic cancer].
    Matsushita N, Kobayashi Y, Tanaka Y, Nakao M, Shimizu K, Takeshita N, Tanigawa K, Aruga A.
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1655-8. PubMed ID: 15553674
    [Abstract] [Full Text] [Related]

  • 12. Natural killer cells in cancer.
    Höglund P, Klein E.
    Semin Cancer Biol; 2006 Oct; 16(5):331-2. PubMed ID: 16931040
    [No Abstract] [Full Text] [Related]

  • 13. Natural killer cell-directed therapies: moving from unexpected results to successful strategies.
    Terme M, Ullrich E, Delahaye NF, Chaput N, Zitvogel L.
    Nat Immunol; 2008 May; 9(5):486-94. PubMed ID: 18425105
    [Abstract] [Full Text] [Related]

  • 14. Human natural killer cells: a comprehensive review.
    Sinkovics JG, Horvath JC.
    Int J Oncol; 2005 Jul; 27(1):5-47. PubMed ID: 15942642
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Adoptive transfer of TRAIL-expressing natural killer cells prevents recurrence of hepatocellular carcinoma after partial hepatectomy.
    Ohira M, Ohdan H, Mitsuta H, Ishiyama K, Tanaka Y, Igarashi Y, Asahara T.
    Transplantation; 2006 Dec 27; 82(12):1712-9. PubMed ID: 17198265
    [Abstract] [Full Text] [Related]

  • 17. Prospects for the use of NK cells in immunotherapy of human cancer.
    Ljunggren HG, Malmberg KJ.
    Nat Rev Immunol; 2007 May 27; 7(5):329-39. PubMed ID: 17438573
    [Abstract] [Full Text] [Related]

  • 18. The role of the NKG2D receptor for tumor immunity.
    Coudert JD, Held W.
    Semin Cancer Biol; 2006 Oct 27; 16(5):333-43. PubMed ID: 16914326
    [Abstract] [Full Text] [Related]

  • 19. Near-infrared emitting fluorescent nanocrystals-labeled natural killer cells as a platform technology for the optical imaging of immunotherapeutic cells-based cancer therapy.
    Lim YT, Cho MY, Noh YW, Chung JW, Chung BH.
    Nanotechnology; 2009 Nov 25; 20(47):475102. PubMed ID: 19875875
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.